Rapid Test for Infliximab Drug Concentration Allows Immediate Dose Adaptation

OBJECTIVES: Therapeutic drug monitoring of infliximab improves treatment outcomes, but available assays to monitor infliximab lack speed to implement treatment algorithms immediately. Our aim is to validate a rapid, lateral flow-based assay (LFA) for quantitative determination of infliximab and to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Stappen, Thomas, Bollen, Lize, Vande Casteele, Niels, Papamichael, Konstantinos, Van Assche, Gert, Ferrante, Marc, Vermeire, Séverine, Gils, Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288585/
https://www.ncbi.nlm.nih.gov/pubmed/27929524
http://dx.doi.org/10.1038/ctg.2016.62

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288585/
https://www.ncbi.nlm.nih.gov/pubmed/27929524
http://dx.doi.org/10.1038/ctg.2016.62

Ejemplares similares